ClinicalTrials.govpublic full text
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis
atopic dermatitis, upadacitinib, abt-494, rinvoq, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 847256
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.